SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74–84. doi:10.1016/j.eururo.2018.08.036
   PubMed Web of Science ®Google Scholar
• Courthod G, Tucci M, Di Maio M, et al. Papillary renal cell carcinoma: a review of the current therapeutic landscape. Crit Rev Oncol Hematol. 2015;96(1):100–112. doi:10.1016/j.critrevonc.2015.05.008
   PubMed Web of Science ®Google Scholar
• Gago-Dominiguez M, Yuan JM, Castelao JE, et al. Family history and risk of renal cell carcinoma. Cancer Epidemiol Biomark Prev. 2011;10:1001–1004.
   Google Scholar
• Tannir NM, Jonasch E, Albiges L, et al. everolimus versus sunitinib prospective evaluation in metastatic non‐clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol. 2016;69(5):866‐874. doi:10.1016/j.eururo.2015.10.049
   PubMed Web of Science ®Google Scholar
• Armstrong AJ, Halabi S, Eisen T, et al. Everolimus versus sunitinib for patients with metastatic non‐clear cell renal cell carcinoma (ASPEN): a multicentre, open‐label, randomised phase 2 trial. Lancet Oncol. 2016;17(3):378–388. doi:10.1016/S1470-2045(15)00515-X
   PubMed Web of Science ®Google Scholar
• Foley EA, Kapoor TM. Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Biol. 2013;14(1):25–37. doi:10.1038/nrm3494
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang Y, Luo H, et al. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis. Cell Death Dis. 2020;11(10):919. doi:10.1038/s41419-020-03104-6
   PubMed Web of Science ®Google Scholar
• Hou Y, Wang Z, Huang S, et al. SKA3 promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma. Cell Death Dis. 2019;10(12):929. doi:10.1038/s41419-019-2163-3
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu Y, Pu S, et al. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling. Breast Cancer Res Treat. 2021;186(1):247–258. doi:10.1007/s10549-020-06078-3
   PubMed Web of Science ®Google Scholar
• Hu DD, Chen HL, Lou LM, et al. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep. 2020;40(2):BSR20194335. doi:10.1042/BSR20194335
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678. doi:10.1038/s41587-020-0546-8
   PubMed Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e11.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Liu CJ, Hu FF, Xia MX, et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771–3772. doi:10.1093/bioinformatics/bty411
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Wang Z, Song Q, Yang Z, et al. Construction of immune-related risk signature for kidney renal papillary cell carcinoma. Cancer Med. 2019;8(1):289–304. doi:10.1002/cam4.1905
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135–145. doi:10.1056/NEJMoa1505917
   PubMed Web of Science ®Google Scholar
• Welburn JP, Grishchuk EL, Backer CB, et al. The human kinetochore Ska1 complex facilitates microtubule depolymerization-coupled motility. Dev Cell. 2009;16(3):374–385. doi:10.1016/j.devcel.2009.01.011
   PubMed Web of Science ®Google Scholar
• Gaitanos TN, Santamaria A, Jeyaprakash AA, et al. Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3. EMBO J. 2009;28(10):1442–1452. doi:10.1038/emboj.2009.96
   PubMed Web of Science ®Google Scholar
• Cheeseman IM, Niessen S, Anderson S, et al. A conserved protein network controls assembly of the outer kinetochore and its ability to sustain tension. Genes Dev. 2004;18(18):2255–2268. doi:10.1101/gad.1234104
   PubMed Web of Science ®Google Scholar
• Zhang Q, Sivakumar S, Chen Y, et al. Ska3 phosphorylated by Cdk1 binds Ndc80 and recruits Ska to kinetochores to promote mitotic progression. Curr Biol. 2017;27(10):1477–1484.e4. doi:10.1016/j.cub.2017.03.060
   PubMed Web of Science ®Google Scholar
• Theis M, Paszkowski-Rogacz M, Buchholz F. SKAnking with Ska3: essential role of Ska3 in cell division revealed by combined phenotypic profiling. Cell Cycle. 2009;8:3435–3437. doi:10.4161/cc.8.21.9813
   PubMed Web of Science ®Google Scholar
• Daum JR, Wren JD, Daniel JJ, et al. Ska3 is required for spindle checkpoint silencing and the maintenance of chromosome cohesion in mitosis. Curr Biol. 2009;19(17):1467–1472. doi:10.1016/j.cub.2009.07.017
   PubMed Web of Science ®Google Scholar
• Li T, Kon N, Jiang L, et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 2012;149(6):1269–1283. doi:10.1016/j.cell.2012.04.026
   PubMed Web of Science ®Google Scholar
• Hager KM, Gu W. Understanding the non-canonical pathways involved in p53-mediated tumor suppression. Carcinogenesis. 2014;35(4):740–746. doi:10.1093/carcin/bgt487
   PubMed Web of Science ®Google Scholar
• Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14(5):359–370. doi:10.1038/nrc3711
   PubMed Web of Science ®Google Scholar
• Wei CL, Wu Q, Vega VB, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006;124(1):207–219. doi:10.1016/j.cell.2005.10.043
   PubMed Web of Science ®Google Scholar
• Strano S, Fontemaggi G, Costanzo A, et al. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. J Biol Chem. 2002;277(21):18817–18826. doi:10.1074/jbc.M201405200
   PubMed Web of Science ®Google Scholar
• Di Como CJ, Gaiddon C, Prives C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol. 1999;19(2):1438–1449. doi:10.1128/MCB.19.2.1438
   PubMed Web of Science ®Google Scholar
• Schärer E, Iggo R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 1992;20(7):1539–1545. doi:10.1093/nar/20.7.1539
   PubMed Web of Science ®Google Scholar
• Wright RH, Castellano G, Bonet J, et al. CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells. Genes Dev. 2012;26(17):1972–1983. doi:10.1101/gad.193193.112
   PubMed Web of Science ®Google Scholar
• Li KK, Ng IO, Fan ST, et al. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma. Liver. 2002;22(3):259–268. doi:10.1046/j.0106-9543.2002.01629.x
   PubMedGoogle Scholar
• Price BD, Hughes-Davies L, Park SJ. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene. 1995;11(1):73–80.
   PubMed Web of Science ®Google Scholar
• Ruan LW, Li PP, Jin LP. SKA3 promotes cell growth in breast cancer by inhibiting PLK-1 protein degradation. Technol Cancer Res Treat. 2020;19:1533033820947488. doi:10.1177/1533033820947488
   Web of Science ®Google Scholar
• Chan YW, Jeyaprakash AA, Nigg EA, et al. Aurora B controls kinetochore-microtubule attachments by inhibiting Ska complex-KMN network interaction. J Cell Biol. 2012;196(5):563–571. doi:10.1083/jcb.201109001
   PubMed Web of Science ®Google Scholar
• Li C, Yang J, Lei S, et al. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis. Brain Res. 2021;1765:147500. doi:10.1016/j.brainres.2021.147500
   PubMed Web of Science ®Google Scholar
• Hu R, Wang MQ, Niu WB, et al. SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway. Cancer Cell Int. 2018;18:183. doi:10.1186/s12935-018-0670-4
   PubMed Web of Science ®Google Scholar
• Liang Y, Zheng Y, Mou K, et al. Inhibition of spindle and kinetochore associated complex subunit 3 suppresses the proliferation and invasion and induced the apoptosis of cutaneous melanoma by affecting the PI3K/Akt pathway. J Biochem Mol Toxicol. 2021;2021:e22895.
   Google Scholar
• Zhang Q, Huang R, Hu H, et al. Integrative analysis of hypoxia-associated signature in pan-cancer. iScience. 2020;23(9):101460. doi:10.1016/j.isci.2020.101460
   PubMed Web of Science ®Google Scholar
• Bhandari V, Li CH, Bristow RG, et al. Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat Commun. 2020;11(1):737. doi:10.1038/s41467-019-14052-x
   PubMed Web of Science ®Google Scholar
• Ye Y, Hu Q, Chen H, et al. Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy. Nat Metab. 2019;1(4):431–444. doi:10.1038/s42255-019-0045-8
   PubMedGoogle Scholar